Clinical Trials Browser

Phase 2 × S 1 (combination) × Breast × Clear all

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

Phase 2 Unknown

Breast Cancer Recurrent

NCT00438100 2015-05-29

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Phase 2 Completed

142 enrolled 4 charts

Breast Neoplasms